0.0409
-0.0008
(-1.92%)
At close: April 17 at 12:59:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,362
2,362
4,440
12,788
9,335
Cost of Revenue
13,475
13,475
3,445
34,168
34,364
Gross Profit
-11,113
-11,113
995
-21,380
-25,029
Operating Expense
202,528
202,528
231,583
241,484
206,740
Operating Income
-213,641
-213,641
-230,588
-262,864
-231,769
Net Non Operating Interest Income Expense
-3,230
-3,230
1,221
629
899
Pretax Income
-216,871
-216,871
-229,366
-268,694
-231,435
Net Income Common Stockholders
-216,871
-216,871
-229,366
-268,694
-231,435
Diluted NI Available to Com Stockholders
-216,871
-216,871
-229,366
-268,694
-231,435
Basic EPS
-0.18
-0.26
-0.49
-1.30
-1.16
Diluted EPS
-0.18
-0.26
-0.49
-1.30
-1.16
Basic Average Shares
826,764.8330
828,098.1340
468,376.2760
206,444.1470
199,585.5620
Diluted Average Shares
826,764.8330
828,098.1340
468,376.2760
206,444.1470
199,585.5620
Total Operating Income as Reported
-213,641
-213,641
-230,587
-262,247
-232,033
Total Expenses
216,003
216,003
235,028
275,652
241,104
Net Income from Continuing & Discontinued Operation
-216,871
-216,871
-229,366
-268,694
-231,435
Normalized Income
-216,871
-216,871
-229,366
-261,618
-231,135
Interest Income
476
476
2,790
1,348
1,668
Interest Expense
3,706
3,706
1,569
719
769
Net Interest Income
-3,230
-3,230
1,221
629
899
EBIT
-213,165
-213,165
-227,797
-267,975
-230,666
EBITDA
-195,402
-195,402
-210,276
-252,689
-218,478
Reconciled Cost of Revenue
13,475
13,475
3,445
34,168
34,364
Reconciled Depreciation
17,763
17,763
17,521
15,286
12,188
Net Income from Continuing Operation Net Minority Interest
-216,871
-216,871
-229,366
-268,694
-231,435
Total Unusual Items Excluding Goodwill
--
--
3,408
-7,076
-300
Total Unusual Items
--
--
3,408
-7,076
-300
Normalized EBITDA
-195,402
-195,402
-210,276
-245,613
-218,178
12/31/2021 - 12/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.1200
-4.00%
ISAB.ST Inhalation Sciences Sweden AB
0.5950
0.00%
ACARIX.ST Acarix AB (publ)
0.2395
+2.57%
ZENI.ST Zenicor Medical Systems AB
2.8000
+0.72%
PRO.ST Promimic AB (publ)
24.50
+2.08%
BRAIN.ST BrainCool AB (publ)
1.8060
-1.63%
PHI.ST Phase Holographic Imaging PHI AB (publ)
1.4300
+4.38%
EPIS-B.ST Episurf Medical AB (publ)
0.1120
-2.44%
QLIFE.ST Qlife Holding AB (publ)
2.0300
-4.25%
CLS-B.ST Clinical Laserthermia Systems AB (publ)
2.9450
-1.67%